84 related articles for article (PubMed ID: 16928298)
1. [Detection of SOCS-1 mRNA expression by RT-PCR in the patients with myeloid leukemia].
Yang HP; Dai M; Zhou HS; Huang L; Zhang DH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):677-80. PubMed ID: 16928298
[TBL] [Abstract][Full Text] [Related]
2. The suppressor of cytokine signaling-1 is constitutively expressed in chronic myeloid leukemia and correlates with poor cytogenetic response to interferon-alpha.
Roman-Gomez J; Jimenez-Velasco A; Castillejo JA; Cervantes F; Barrios M; Colomer D; Heiniger A; Torres A
Haematologica; 2004 Jan; 89(1):42-8. PubMed ID: 14754605
[TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of 9q34 deletion and the suppressor of cytokine signalling-1 in CML patients.
Ghaith F; Abdou S; El-Bendary A; Shahin D; Eid M; Megeed WA; El-Sheikh I; Farrag W; Yousuf S
Int J Lab Hematol; 2010 Feb; 32(1 Pt 2):103-12. PubMed ID: 19222642
[TBL] [Abstract][Full Text] [Related]
4. Gene expression of helicase antigen in patients with acute and chronic myeloid leukemia.
Chen Q; Lin J; Qian J; Yao DM; Qian W; Li Y; Chai HY; Yang J; Wang CZ; Zhang M; Xiao GF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1171-5. PubMed ID: 22040965
[TBL] [Abstract][Full Text] [Related]
5. The SOCS-1 gene methylation in chronic myeloid leukemia patients.
Hatirnaz O; Ure U; Ar C; Akyerli C; Soysal T; Ferhanoğlu B; Ozçelik T; Ozbek U
Am J Hematol; 2007 Aug; 82(8):729-30. PubMed ID: 17315216
[TBL] [Abstract][Full Text] [Related]
6. [Gene of DNA-dependent protein kinase catalylic subunit in chronic myeloid leukemia].
Luo J; Peng ZG; Chen Y; Lai YR; Lu YY; Song SJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):248-52. PubMed ID: 17493325
[TBL] [Abstract][Full Text] [Related]
7. [Detection of phosphotyrosine in chronic myeloid leukemia cells with PY20 antibody and its clinical applications].
Tian J; Cheng H; Xu KL; Pan XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):1056-60. PubMed ID: 19698259
[TBL] [Abstract][Full Text] [Related]
8. Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.
Paschka P; Müller MC; Merx K; Kreil S; Schoch C; Lahaye T; Weisser A; Petzold A; König H; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
Leukemia; 2003 Sep; 17(9):1687-94. PubMed ID: 12970765
[TBL] [Abstract][Full Text] [Related]
9. [Monitoring bcr-abl mRNA levels by real-time quantitative RT-PCR in chronic myeloid leukemia patients after hematopoietic stem cell transplantation].
Qin YZ; Li JL; Zhu HH; Ruan GR; Li LD; Zhang Y; Xu LP; Liu DH; Liu YR; Huang XJ; Chen SS; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):511-4. PubMed ID: 17172121
[TBL] [Abstract][Full Text] [Related]
10. Constitutive expression of SOCS3 confers resistance to IFN-alpha in chronic myelogenous leukemia cells.
Sakai I; Takeuchi K; Yamauchi H; Narumi H; Fujita S
Blood; 2002 Oct; 100(8):2926-31. PubMed ID: 12351404
[TBL] [Abstract][Full Text] [Related]
11. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
[TBL] [Abstract][Full Text] [Related]
12. [Expression of c-fes gene in leukemia cells and its clinical significance].
Zhang YL; Ren JH; Guo XN; Zhang JN; Wang Y; Qiao SK; Lin FR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1429-33. PubMed ID: 20030920
[TBL] [Abstract][Full Text] [Related]
13. Possible correlation between fusion pattern of BCR/ABL mRNA and clinical response to alpha-interferon in chronic myelogenous leukemia.
Inoue T; Tojo A; Tsuchimoto D; Okamoto S; Ogura H; Tani K; Ozawa K; Shibuya M; Asano S
Leukemia; 1992 Sep; 6(9):948-51. PubMed ID: 1518306
[TBL] [Abstract][Full Text] [Related]
14. [Down-regulation of transcription factor PU.1 via abnormal epigenetic modification in chronic myeloid leukemia].
Yang H; Yan JS; Tao R; Hao SG; Liang H; Ma LY
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):169-75. PubMed ID: 22780968
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of therapeutic effects of low-dose versus high-dose interferon alpha-2b treatment on chronic myelocytic leukemia: a prospective randomized study].
Du JW; Zhu P; Tian D; Dong ZR; Yang SL; Li SB; Tang YH; Liu H; Cen XN; Zhang Y; Zhu Q; Zhu YL; Yang Y; Wang DX; Wang Z; Cui H; Ma YG; Chen WM; Liu FQ; Ma J; Wang JW; Shen T; Da WM
Zhonghua Yi Xue Za Zhi; 2005 May; 85(19):1305-9. PubMed ID: 16029627
[TBL] [Abstract][Full Text] [Related]
16. Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha.
Merx K; Müller MC; Kreil S; Lahaye T; Paschka P; Schoch C; Weisser A; Kuhn C; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
Leukemia; 2002 Sep; 16(9):1579-83. PubMed ID: 12200666
[TBL] [Abstract][Full Text] [Related]
17. [Study on mismatch repair genes of chronic myeloid leukemia].
Luo J; Peng ZG; Chen Y; Lai YR; Lu YY; Song SJ
Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):103-6. PubMed ID: 16732964
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
19. [Monitoring of the therapeutic response of interferon to chronic myeloid leukemia by duel-color fluorescence in situ hybridization].
Song YQ; Li W; Kong LH; Wang GJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):38-40. PubMed ID: 12667287
[TBL] [Abstract][Full Text] [Related]
20. [Study on the relationship between the expression of SOCS-1/3 in the peripheral blood mononuclear cells in patients with multiple organ dysfunction syndrome and their prognosis].
Chen ZB; Liang YB; Tang H; Lin XS; He DH; Ma ZF
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Jan; 20(1):29-33. PubMed ID: 18199397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]